Study of Mana 312 (Multi Tumor-Associated Antigen T Cells) in Adults With AML/MDS After HSCT
Clinical trial NCT04679194 · TERMINATED
Trial details
- NCT number
- NCT04679194
- Sponsor
- Mana Therapeutics
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-08
- Primary completion
- 2023-03-28
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.